pharmaceutical industry

This Teen Was Prescribed 10 Psychiatric Drugs. She’s Not Alone

“Increasingly, anxious and depressed teens are using multiple, powerful psychiatric drugs, many of them untested in adolescents or for use in tandem.” This article by Matt Richtel has been published in the New York Times. It begins: “One morning in the…
Read more

Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs

This book (with relevance to the psychiatry’s prescribing of psychotropic drugs on a massive scale) has been written by investigative journalist Melody Petersen. The publishers say: “In an odyssey into the dark side of American medicine, an award-winning journalist reveals how…
Read more

The Fight for Pharma Accountability and Psychiatric Rights: Jim Gottstein, Esq

Dr. Awais Aftab (psychiatrist) has interviewed Jim Gottstein for the Psychiatric Times. Subtitled “A lawyer weighs in on pharmaceutical corruption and involuntary psychiatric care”. The introduction to the interview begins: “The Zyprexa Papers is a fascinating story of how Gottstein obtained and…
Read more

How to take the news that depression has not been shown to be caused by a chemical imbalance

This article is from psychiatrist Dr. Joanna Moncrieff. It begins: “For decades people have been told that depression is caused by a serotonin deficiency. This was the rationale behind the introduction of the SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants in the…
Read more

A Decisive Blow to the Serotonin Hypothesis of Depression

This article by Christopher Lane has been published in Psychology Today. It begins: “Almost as soon as it was floated in 1965 by Harvard psychiatrist Joseph Schildkraut, the serotonin hypothesis of  depression —reduced and simplified by pharma marketing to the ‘chemical imbalance’…
Read more

Drug Companies & Doctors: A Story of Corruption

This article (published on the medicinehitchiker blog) has been written by Dr. Marcia Angell, former Editor in Chief of The New England Journal of Medicine. It begins: “Recently Senator Charles Grassley, ranking Republican on the Senate Finance Committee, has been looking…
Read more

From FDA to MHRA: are drug regulators for hire?

This article by Maryanne Demasi has been published in the British Medical Journal: “Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies…
Read more

How Drugmakers Influence Our Beliefs About Mental Illness

This article by Markham Heid has been published on the Medium website. It begins: “Nothing burns itself into memory quite like public humiliation. Even now, 20 years later, I can vividly recall the embarrassment I felt the day I tried —…
Read more

Ethical issues in psychopharmacology

This paper by L. McHenry has been published in the Journal of Medical Ethics. The abstract says: “The marketing of selective serotonin reuptake inhibitors in the psychopharmacological industry presents a serious moral problem for the corporate model of medicine. In this…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU